Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology
- PMID: 24818077
- PMCID: PMC3984448
- DOI: 10.1016/j.nicl.2014.03.005
Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology
Abstract
The relationships between clinical phenotype, β-amyloid (Aβ) deposition and neurodegeneration in Alzheimer's disease (AD) are incompletely understood yet have important ramifications for future therapy. The goal of this study was to utilize multimodality positron emission tomography (PET) data from a clinically heterogeneous population of patients with probable AD in order to: (1) identify spatial patterns of Aβ deposition measured by ((11)C)-labeled Pittsburgh Compound B (PiB-PET) and glucose metabolism measured by FDG-PET that correlate with specific clinical presentation and (2) explore associations between spatial patterns of Aβ deposition and glucose metabolism across the AD population. We included all patients meeting the criteria for probable AD (NIA-AA) who had undergone MRI, PiB and FDG-PET at our center (N = 46, mean age 63.0 ± 7.7, Mini-Mental State Examination 22.0 ± 4.8). Patients were subclassified based on their cognitive profiles into an amnestic/dysexecutive group (AD-memory; n = 27), a language-predominant group (AD-language; n = 10) and a visuospatial-predominant group (AD-visuospatial; n = 9). All patients were required to have evidence of amyloid deposition on PiB-PET. To capture the spatial distribution of Aβ deposition and glucose metabolism, we employed parallel independent component analysis (pICA), a method that enables joint analyses of multimodal imaging data. The relationships between PET components and clinical group were examined using a Receiver Operator Characteristic approach, including age, gender, education and apolipoprotein E ε4 allele carrier status as covariates. Results of the first set of analyses independently examining the relationship between components from each modality and clinical group showed three significant components for FDG: a left inferior frontal and temporoparietal component associated with AD-language (area under the curve [AUC] 0.82, p = 0.011), and two components associated with AD-visuospatial (bilateral occipito-parieto-temporal [AUC 0.85, p = 0.009] and right posterior cingulate cortex [PCC]/precuneus and right lateral parietal [AUC 0.69, p = 0.045]). The AD-memory associated component included predominantly bilateral inferior frontal, cuneus and inferior temporal, and right inferior parietal hypometabolism but did not reach significance (AUC 0.65, p = 0.062). None of the PiB components correlated with clinical group. Joint analysis of PiB and FDG with pICA revealed a correlated component pair, in which increased frontal and decreased PCC/precuneus PiB correlated with decreased FDG in the frontal, occipital and temporal regions (partial r = 0.75, p < 0.0001). Using multivariate data analysis, this study reinforced the notion that clinical phenotype in AD is tightly linked to patterns of glucose hypometabolism but not amyloid deposition. These findings are strikingly similar to those of univariate paradigms and provide additional support in favor of specific involvement of the language network, higher-order visual network, and default mode network in clinical variants of AD. The inverse relationship between Aβ deposition and glucose metabolism in partially overlapping brain regions suggests that Aβ may exert both local and remote effects on brain metabolism. Applying multivariate approaches such as pICA to multimodal imaging data is a promising approach for unraveling the complex relationships between different elements of AD pathophysiology.
Keywords: AD or AD-memory, Alzheimer's disease; AD-language or LPA, logopenic variant primary progressive aphasia; AUC, area under the curve; Alzheimer's disease; Amyloid imaging; FDG-PET; Functional connectivity; Multivariate data analysis; Networks; PCA or AD-visuospatial, posterior cortical atrophy; PCC, posterior cingulate cortex; PPC, posterior parietal cortex; Parallel ICA; PiB-PET.
Figures


Similar articles
-
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Brain. 2016 May;139(Pt 5):1551-67. doi: 10.1093/brain/aww027. Epub 2016 Mar 8. Brain. 2016. PMID: 26962052 Free PMC article.
-
Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1927-36. doi: 10.1007/s00259-012-2230-9. Epub 2012 Aug 28. Eur J Nucl Med Mol Imaging. 2012. PMID: 22926714
-
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.Brain. 2013 Mar;136(Pt 3):844-58. doi: 10.1093/brain/aws327. Epub 2013 Jan 28. Brain. 2013. PMID: 23358601 Free PMC article.
-
Early detection of Alzheimer's disease using PiB and FDG PET.Neurobiol Dis. 2014 Dec;72 Pt A:117-22. doi: 10.1016/j.nbd.2014.05.001. Epub 2014 May 10. Neurobiol Dis. 2014. PMID: 24825318 Free PMC article. Review.
-
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Semin Nucl Med. 2011. PMID: 21624562 Review.
Cited by
-
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease.Neuroimage Clin. 2017 Sep 25;17:452-464. doi: 10.1016/j.nicl.2017.09.016. eCollection 2018. Neuroimage Clin. 2017. PMID: 29159058 Free PMC article.
-
Electroacupuncture reduces scopolamine-induced amnesia via mediating the miR-210/SIN3A and miR-183/SIN3A signaling pathway.Mol Med. 2020 Nov 12;26(1):107. doi: 10.1186/s10020-020-00233-8. Mol Med. 2020. PMID: 33183243 Free PMC article.
-
Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment.J Alzheimers Dis. 2020;73(2):543-557. doi: 10.3233/JAD-190560. J Alzheimers Dis. 2020. PMID: 31796668 Free PMC article.
-
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1470-1486. doi: 10.1007/s00259-018-4024-1. Epub 2018 Apr 30. Eur J Nucl Med Mol Imaging. 2018. PMID: 29713763 Review.
-
High and Low Levels of an NTRK2-Driven Genetic Profile Affect Motor- and Cognition-Associated Frontal Gray Matter in Prodromal Huntington's Disease.Brain Sci. 2018 Jun 22;8(7):116. doi: 10.3390/brainsci8070116. Brain Sci. 2018. PMID: 29932126 Free PMC article.
References
-
- Cohen A.D., Price J.C., Weissfeld L.A., James J., Rosario B.L., Bi W. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2009;29(47):14770–14778. doi: 10.1523/JNEUROSCI.3669-09.2009. 19940172 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous